Full Spectrum Laboratories Secures U.S. Cannabinoid Biosynthesis Patent

News   Jan 09, 2017 | Original Story From Teewinot Life Sciences Corporation

 
Full Spectrum Laboratories Secures U.S. Cannabinoid Biosynthesis Patent
 
 
 
 

RELATED ARTICLES

ACD/Labs Collaboration Provides NMR Data to Brazilian Biodiversity Natural Products Database

News

ACD/Labs announces collaboration with researchers at Brazilian Biodiversity database in support of chemical and pharmaceutical R&D.

READ MORE

Specific Gene Combinations Linked to Glioblastoma

News

A Yale-led team of researchers has identified specific gene combinations that can cause the deadly brain cancer glioblastoma, using new technology that can also pinpoint triggers of other types cancers.

READ MORE

A Promising Framework for Predicting Drug Resistance in Cancer

News

The system works by predicting the co-occurrence of about 500 known tumour alterations, as well as their response to over 200 common cancer drugs.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE